Effect of estimated prostate volume on silodosin-mediated improvements in the signs and symptoms of BPH: does prostate size matter?

OBJECTIVE: The uroselective α-blocker silodosin significantly improved International Prostate Symptom Score (IPSS) in two 12-week, double-blind (DB), placebo-controlled Phase III studies in men aged ≥ 50 years with symptoms of benign prostatic hyperplasia (BPH) and maintained symptom improvement dur...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaplan, Steven A, Roehrborn, Claus G, Hill, Lawrence A, Volinn, Weining
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818948/
https://www.ncbi.nlm.nih.gov/pubmed/24198640
http://dx.doi.org/10.2147/OAJU.S18941

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818948/
https://www.ncbi.nlm.nih.gov/pubmed/24198640
http://dx.doi.org/10.2147/OAJU.S18941

Ejemplares similares